Wednesday 6 November 2024
 
»
 
»
Story

Therapies for psoriasis patients discussed

Muscat, February 26, 2008

Fifty dermatologists from across the region attended the First GCC Biologics’ Forum at the Shangri-La Hotel in Muscat recently.

The forum sponsored by Wyeth Pharmaceuticals, was given by Professsor Richard Langley, Associate Professor of Medicine & Director of Research at Dalhouise University, Halifax, Canada.

Prof Langley discussed the British Association of Dermatologists Guidelines, along with his personal guidelines on the use of Biological therapies on Psoriasis patients.

The objective of the forum was to increase awareness of the practical aspects of “biologics”, by clarifying who should be treated and how to initiate biological therapy. Also, a discussion on drafting the GCC guidelines for the use of biologics was initiated.

Psoriasis is a long-lasting skin disease that affects both men and women and is visible on the skin in the form of red itchy scales. Psoriasis usually appears on the elbows and knees of the patient, but sometimes may affect the lower back, face and the feet.

“Affecting more than two percent of UAE’s population, psoriasis has a profound negative impact on the quality of life and in many cases may lead the sufferer into a state of depression,” says Dr Hussein Abdel Dayem, head of Dermatology Department, Mafraq Hospital.

“There is a need for new therapies with fewer side effects, especially for patients with severe psoriasis that are undergoing extensive therapies,” he added.

Biological therapies or ‘biologics’ have emerged over the last three to five years as a potentially therapeutic option to psoriasis, but since clinical history and long-term results are limited certain guidelines have been developed to guarantee a systematic, safe and effective treatment process for psoriasis patients.

“The results I have seen from biologics have been terrific on most of my patients, especially when treating moderate to severe psoriasis but guidelines prescribing biologics is a must, to maximise treatment effectiveness and ensure that the correct biologic treatment is presented for the patient,” said Prof Langley. - TradeArabia News Service




Tags: Health | forum | Dermatologists | Biologics |

More Health & Environment Stories

calendarCalendar of Events

Ads